Maravai LifeSciences Holdings, Inc. MRVI Income Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $65.84M+40.5% | $49.87M-11.8% | $41.63M-39.7% | $47.4M-31.7% | $46.85M-27.0% | ||
| $32.14M-17.9% | $37.02M-0.4% | $35.98M-2.2% | $39.63M+2.7% | $39.13M+2.1% | ||
| $33.7M+336% | $12.84M-33.8% | $5.66M-82.5% | $7.77M-74.8% | $7.73M-70.1% | ||
| 51.2%+34.7pp | 25.8%-8.5pp | 13.6%-33.1pp | 16.4%-28.0pp | 16.5%-23.8pp | ||
| $3.89M-20.4% | $3.79M-16.9% | $3.84M-18.3% | $4.88M-0.9% | $4.89M-2.9% | ||
| $29.09M-26.5% | $31.58M-23.4% | $35.4M-9.4% | $38.58M-4.9% | $39.56M-3.2% | ||
| $2.88M— | $10.44M— | $7.39M+184,750% | $0+100% | $0+100% | ||
| $0-100% | —— | $0-100% | $30.45M— | $12.44M— | ||
| $35.86M-37.0% | $71.64M+25.5% | $46.69M-76.4% | $113.68M+37.2% | $56.89M-31.5% | ||
| -$2.16M+95.6% | -$58.8M-55.9% | -$41.03M+75.2% | -$66.28M-393% | -$49.16M-161% | ||
| -3.3%+102pp | -117.9%-51.2pp | -98.6%+141pp | -139.8%-120pp | -104.9%-75.5pp | ||
| $5.75M-15.2% | $6.56M-41.8% | $6.84M-49.8% | $6.82M-42.9% | $6.78M-37.6% | ||
| $1.87M-41.9% | $2.38M-60.5% | $2.8M-60.4% | $3.03M-57.2% | $3.23M-55.3% | ||
| -$494K-2,158% | -$43K— | -$71K-199% | -$4.06M-58.5% | $24K-77.4% | ||
| -$6.53M+87.6% | -$63.01M-36.8% | -$45.15M+73.8% | -$74.13M-255% | -$52.69M-135% | ||
| -$151K-193% | $0+100% | -$92K-130% | -$4.29M-76.1% | $162K-40.2% | ||
| -$3.73M+87.5% | -$35.68M-37.7% | -$25.56M+73.7% | -$39.59M-304% | -$29.95M-148% | ||
| -5.7%+58.2pp | -71.6%-25.8pp | -61.4%+79.2pp | -83.5%-69.4pp | -63.9%-45.1pp | ||
| -$0.02+90.5% | -$0.24-33.3% | -$0.18+73.5% | -$0.27-286% | -$0.21-133% | ||
| -$0.02+90.5% | -$0.24-33.3% | -$0.18+73.5% | -$0.27-286% | -$0.21-133% | ||
| 146.4M+2.1% | 144.4M+4.7% | 144.7M+2.2% | 144.2M+6.2% | 143.4M+8.4% | ||
| 146.4M+2.1% | 144.4M+4.7% | 144.7M+2.2% | 144.2M+6.2% | 143.4M+8.4% | ||
| —— | $17.18M-58.6% | $17.18M-58.6% | $17.18M-58.6% | $17.18M-58.6% | ||
| -$494K-2,158% | -$43K— | -$71K-199% | -$4.06M-58.5% | $24K-77.4% | ||
| $65.84M+40.5% | $49.87M-11.8% | $41.63M-39.7% | $47.4M-31.7% | $46.85M-27.0% | ||
| -$2.16M+95.6% | -$58.8M-55.9% | -$41.03M+75.2% | -$66.28M-393% | -$49.16M-161% | ||
| $9.21M+125% | -$46.35M-83.0% | -$27.85M+81.9% | -$53.12M-5,134% | -$36.44M-406% | ||
| $9.21M+125% | -$46.35M-83.0% | -$27.85M+81.9% | -$53.12M-5,134% | -$36.44M-406% | ||
| 14%+91.8pp | -92.9%-48.2pp | -66.9%+156pp | -112.1%-111pp | -77.8%-66.6pp | ||
| -$2.16M+95.6% | -$58.8M-55.9% | -$41.03M+75.2% | -$66.28M-393% | -$49.16M-161% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s revenue?
- Maravai LifeSciences Holdings, Inc. (MRVI) generated $204.7M in revenue over the trailing twelve months, down 15.3% year over year.
- Is Maravai LifeSciences Holdings, Inc. profitable?
- Maravai LifeSciences Holdings, Inc. is not currently profitable: it reported a net loss of $104.6M over the trailing twelve months, a -51.1% net margin.
- What are Maravai LifeSciences Holdings, Inc.'s profit margins?
- Gross margin is 29.3% and operating margin is -82.2%, with a -51.1% net margin.
- What is Maravai LifeSciences Holdings, Inc.'s earnings per share?
- Maravai LifeSciences Holdings, Inc.'s diluted EPS over the trailing twelve months is $-0.71.
- Where does Maravai LifeSciences Holdings, Inc.'s income statement data come from?
- Every line is extracted from Maravai LifeSciences Holdings, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
